The weight loss drugs market share is witnessing transformative dynamics as the sector anticipates a remarkable growth trajectory. With the market expected to expand from USD 54.53 billion in 2024 to approximately USD 379.28 billion by 2035, a compound annual growth rate (CAGR) of 19.28% will redefine competitive positioning. This growth reflects an urgent response to the obesity epidemic, with...